South Africa Urged To Revoke Key COVID-19 Patents

Lilly's Baricitinib Patent Is Claimed To Be Limiting Access To Affordable Generics

 
• By Chloe Kent
  
Eli Lilly world headquarters
MSF has its sights set on Lilly • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet